CNTA
Centessa Pharmaceuticals
CNTA
CNTA
80 hedge funds and large institutions have $781M invested in Centessa Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.33% more ownership
Funds ownership: 76.2% → 76.53% (+0.33%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
7% less capital invested
Capital invested by funds: $841M → $781M (-$59.5M)
Holders
80
Holding in Top 10
5
Calls
$119K
Puts
$27K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$14.7M | |
| 3 | +$9.48M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.92M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.9M |
Top Sellers
| 1 | -$4.48M | |
| 2 | -$2.64M | |
| 3 | -$2.15M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$1.41M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$1.02M |